Partial changes in apoptotic pathways in hippocampus and hypothalamus of Cc2d1a heterozygous

Elif Funda Sener1,2, Halime Dana3,4, Reyhan Tahtasakal3,4

  • 1Department of Medical Biology, Erciyes University Medical Faculty, 38039, Kayseri, Turkey. efefunda@yahoo.com.

Metabolic Brain Disease
|December 1, 2022
PubMed

Insights

CC2D1A gene alterations impact apoptosis pathways, potentially affecting serotonin signaling in autism. Studies in Cc2d1a+/- mice revealed increased apoptotic cells, suggesting partial involvement in autism pathogenesis.

Area of Science:

  • Neuroscience
  • Genetics
  • Cell Biology

Background:

  • Alterations in apoptosis pathways are implicated in autism spectrum disorder (ASD).
  • The CC2D1A gene, a repressor of the serotonin pathway gene HTR1A, is linked to ASD pathogenesis.
  • Serotonin signaling is frequently altered in autistic individuals.

Purpose of the Study:

  • To investigate the role of CC2D1A in apoptosis regulation within brain regions relevant to autism.
  • To analyze the expression of key apoptosis markers in a Cc2d1a heterozygous mouse model.
  • To explore potential gender-specific differences in apoptosis and behavior.

Main Methods:

  • Analysis of apoptosis markers (caspase 3, 8, and 9) in the hippocampus and hypothalamus of Cc2d1a+/- mice.
  • Behavioral assessment using the open-field assay.
  • Quantification of apoptotic cells.

Main Results:

  • Significant increases in the number of apoptotic cells were observed in Cc2d1a+/- mice.
  • Gender differences were noted in the expression levels of caspases 3, 8, and 9.
  • Altered caspase expression suggests a partial disruption of the apoptotic pathway.

Conclusions:

  • Apoptotic pathways are partially affected in the Cc2d1a heterozygous mouse model relevant to autism.
  • Downregulation of Caspase 8 and Caspase 3 expression indicates a potential suppression or incomplete activation of apoptosis.
  • These findings contribute to understanding the complex interplay between CC2D1A, serotonin, and apoptosis in neurodevelopmental disorders.